Welcome to our dedicated page for Milestone Scient news (Ticker: MLSS), a resource for investors and traders seeking the latest updates and insights on Milestone Scient stock.
Milestone Scient (MLSS) delivers innovative computer-controlled anesthetic systems designed to improve patient comfort in dental and medical procedures. This dedicated news hub provides real-time updates on the company’s technological advancements, regulatory milestones, and strategic partnerships.
Access authoritative information on MLSS’s global expansion across 25+ countries, product innovations like the CompuDent and CompuMed systems, and financial performance. The curated content serves investors and healthcare professionals seeking to monitor the company’s impact on pain management technology.
Key updates include FDA clearances, clinical trial results, partnership announcements with medical institutions, and market penetration strategies. All content is sourced directly from official company communications to ensure accuracy and timeliness.
Bookmark this page for streamlined access to MLSS’s latest developments, enabling data-driven insights into its role in advancing precision anesthetic delivery worldwide.
Milestone Scientific Inc. (NYSE: MLSS) reported a decline in 2022 revenues of $8.8 million, down from $10.3 million in 2021, attributed mainly to a $1.4 million drop in sales from China and a decrease in domestic dental revenue. The company faced an operating loss of $8.8 million, compared to $7.4 million the previous year. Despite these challenges, Milestone made progress in its product rollout, particularly the CompuFlo® Epidural System, which received FDA clearance for thoracic applications, potentially enhancing its market penetration. The company also launched a new online store for dental products, aiming for improved customer relations and profitability.
Milestone Scientific (NYSE:MLSS) will host a conference call on March 31, 2023, at 8:30 AM ET to discuss its 2022 financial results and corporate developments. U.S. callers can dial toll-free 888-506-0062, while international callers can reach the call at +1 973-528-0011, using access code 333430. An audio replay will be available until April 15, 2023, by calling 877-481-4010 for U.S. callers and +1 919-882-2331 for international. The company is known for its advanced computerized drug delivery instruments that facilitate painless injections, utilizing patented DPS Dynamic Pressure Sensing Technology® for improved patient safety and comfort.
Milestone Scientific Inc. (NYSE: MLSS), a leader in computerized drug delivery instruments, has begun sales of its CompuFlo® Epidural disposables at the University Pain and Spine Center, following a successful evaluation by Dr. Didier Demesmin. Dr. Demesmin endorses the CompuFlo Epidural Instrument for its objective measurement capabilities, enhancing procedure safety and speed. CEO Arjan Haverhals emphasized the importance of this adoption for establishing the CompuFlo Epidural System as the standard in epidural analgesia, boosted by recent FDA clearance for thoracic spine use, a significant step for market penetration.
FAQ
What is the current stock price of Milestone Scient (MLSS)?
What is the market cap of Milestone Scient (MLSS)?
